Vanguard Group Inc Aurinia Pharmaceuticals Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,720,878 shares of AUPH stock, worth $21.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,720,878

Previous 1,971,806 12.73%

Holding current value

$21.2 Million

Previous $15.9 Million 8.06%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$7.2 - $8.64 $1.81 Million - $2.17 Million	-250,928 Reduced 12.73%	1,720,878 $14.6 Million
Q1 2025 May 09, 2025	BUY	$7.55 - $8.77 $1.83 Million - $2.12 Million	241,858 Added 13.98%	1,971,806 $15.9 Million
Q4 2024 Feb 11, 2025	BUY	$6.75 - $10.44 $756,762 - $1.17 Million	112,113 Added 6.93%	1,729,948 $15.5 Million
Q3 2024 Nov 13, 2024	BUY	$5.32 - $7.33 $418,806 - $577,039	78,723 Added 5.11%	1,617,835 $11.9 Million
Q2 2024 Aug 13, 2024	BUY	$4.81 - $5.78 $36,050 - $43,321	7,495 Added 0.49%	1,539,112 $8.79 Million
Q1 2024 May 10, 2024	BUY	$4.93 - $9.31 $104,116 - $196,617	21,119 Added 1.4%	1,531,617 $7.67 Million
Q4 2023 Mar 11, 2024	BUY	$7.13 - $9.49 $9,532 - $12,688	1,337 Added 0.09%	1,510,498 $13.6 Million
Q4 2023 Feb 14, 2024	BUY	$7.13 - $9.49 $177,487 - $236,234	24,893 Added 1.68%	1,509,161 $13.6 Million
Q3 2023 Nov 14, 2023	BUY	$7.77 - $12.27 $790,605 - $1.25 Million	101,751 Added 7.36%	1,484,268 $11.5 Million
Q2 2023 Aug 14, 2023	BUY	$8.96 - $11.69 $487,486 - $636,017	54,407 Added 4.1%	1,382,517 $13.4 Million
Q1 2023 May 15, 2023	SELL	$5.94 - $11.27 $275,693 - $523,074	-46,413 Reduced 3.38%	1,328,110 $14.6 Million
Q4 2022 Feb 10, 2023	BUY	$4.11 - $8.14 $686,016 - $1.36 Million	166,914 Added 13.82%	1,374,523 $5.94 Million
Q3 2022 Nov 14, 2022	BUY	$6.66 - $12.39 $257,422 - $478,898	38,652 Added 3.31%	1,207,609 $9.08 Million
Q2 2022 Aug 12, 2022	BUY	$8.95 - $12.8 $5.72 Million - $8.18 Million	638,898 Added 120.53%	1,168,957 $11.7 Million
Q1 2022 May 13, 2022	BUY	$10.05 - $22.48 $1.11 Million - $2.48 Million	110,354 Added 26.29%	530,059 $6.56 Million
Q4 2021 Feb 14, 2022	BUY	$17.78 - $33.08 $6.17 Million - $11.5 Million	347,094 Added 478.02%	419,705 $9.6 Million
Q3 2021 Nov 12, 2021	BUY	$10.93 - $23.55 $819 - $1,766	75 Added 0.1%	72,611 $1.61 Million
Q2 2021 Aug 13, 2021	BUY	$10.0 - $14.52 $725,360 - $1.05 Million	72,536 New	72,536 $940,000

Others Institutions Holding AUPH

# of Institutions

243

Shares Held

62.4M

Call Options Held

1.03M

Put Options Held

666K

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.75B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Aurinia Pharmaceuticals Inc. Transaction History